Skip to main content
Clinical Trials/NCT02931734
NCT02931734
Completed
N/A

Analysis of the Association of Products for the Treatment of Cervical Dentin Hypersensitivity

Federal University of Uberlandia1 site in 1 country140 target enrollmentOctober 2014

Overview

Phase
N/A
Intervention
Resin modified glass ionomer
Conditions
Hypersensitivity Dentin
Sponsor
Federal University of Uberlandia
Enrollment
140
Locations
1
Primary Endpoint
Level of cervical dentin hypersensitivity, measured by visual analog scale
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The aim of this study is through a randomized clinical trial, double blind, splith-mouth, evaluate the various types of protocols and clinical efficacy in the reduction or even elimination of dentinal hypersensitivity by the agents Desensibilize KF - FGM Dental Products, Clinpro - 3M Company, Minnesota - USA, Photon Laser III - DMC, Brazil, Desensibilize KF and laser, Desensibilize KF and Clinpro, laser and Clinpro and the association of all products. Data will be collected, tabulated and submitted to statistical analysis.

Detailed Description

Cervical dentin hypersensitivity is a painful condition and is a clinical challenge due to different treatment strategies available. The aim of this study is through a randomized clinical trial, double blind, splith-mouth, evaluate the various types of protocols and clinical efficacy in the reduction or even elimination of dentinal hypersensitivity. A hundred forty teeth of healthy patients of both sexes were selected. Visual Analog Scale was used pain (VAS) to measure the intensity of the patient's pain. The teeth will be randomly divided into 7 different groups according to the desensitization treatment under study: Desensibilize KF - FGM Dental Products, Clinpro - 3M Company, Minnesota - USA, Photon Laser III - DMC, Brazil, Desensibilize KF and laser, Desensibilize KF and Clinpro, laser and Clinpro and the association of all products. Data will be collected, tabulated and submitted to statistical analysis.

Registry
clinicaltrials.gov
Start Date
October 2014
End Date
July 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Federal University of Uberlandia
Responsible Party
Principal Investigator
Principal Investigator

PAULO VINICIUS SOARES

Professor

Federal University of Uberlandia

Eligibility Criteria

Inclusion Criteria

  • presence of dentin exposure lesions with clinical diagnosis of moderate or severe tooth sensitivity
  • good oral hygiene.

Exclusion Criteria

  • cavities,
  • presence of periodontal disease and or parafunctional habits,
  • cracks or enamel fractures,
  • extensive or unsatisfactory restorations,
  • recent restorations involving the labial surface,
  • dentures,
  • orthodontics.

Arms & Interventions

RMGI and KF

Resin modified glass ionomer and potassium nitrate and sodium fluoride 2%; an application of the two associated products, every 48 hours; 4 sessions.

Intervention: Resin modified glass ionomer

Resin modified glass ionomer (RMGI)

Resin modified glass ionomer; an application every 48 hours; 4 sessions.

Intervention: Resin modified glass ionomer

Potassium Nitrate 2% (KF)

Potassium Nitrate and Sodium fluoride 2%; an application every 48 hours; 4 sessions.

Intervention: Potassium Nitrate 2%

Low level laser therapy - GaAlAs (LLLT)

Low level laser therapy - GaAlAs; an application every 48 hours; 4 sessions.

Intervention: Low level laser therapy

RMGI and KF

Resin modified glass ionomer and potassium nitrate and sodium fluoride 2%; an application of the two associated products, every 48 hours; 4 sessions.

Intervention: Potassium Nitrate 2%

RMGI and LLLT

Resin modified glass ionomer and Low level laser therapy - GaAlAs; an application of the two associated products, every 48 hours; 4 sessions.

Intervention: Resin modified glass ionomer

RMGI and LLLT

Resin modified glass ionomer and Low level laser therapy - GaAlAs; an application of the two associated products, every 48 hours; 4 sessions.

Intervention: Low level laser therapy

KF and LLLT

Potassium Nitrate and Sodium fluoride 2% and Low level laser therapy - GaAlAs; an application of the two associated products, every 48 hours; 4 sessions.

Intervention: Potassium Nitrate 2%

KF and LLLT

Potassium Nitrate and Sodium fluoride 2% and Low level laser therapy - GaAlAs; an application of the two associated products, every 48 hours; 4 sessions.

Intervention: Low level laser therapy

RMGI, KF, LLLT

Resin modified glass ionomer, potassium nitrate and sodium fluoride 2% and Low level laser therapy - GaAlAs ; an application of the three associated products, every 48 hours; 4 sessions.

Intervention: Resin modified glass ionomer

RMGI, KF, LLLT

Resin modified glass ionomer, potassium nitrate and sodium fluoride 2% and Low level laser therapy - GaAlAs ; an application of the three associated products, every 48 hours; 4 sessions.

Intervention: Potassium Nitrate 2%

RMGI, KF, LLLT

Resin modified glass ionomer, potassium nitrate and sodium fluoride 2% and Low level laser therapy - GaAlAs ; an application of the three associated products, every 48 hours; 4 sessions.

Intervention: Low level laser therapy

Outcomes

Primary Outcomes

Level of cervical dentin hypersensitivity, measured by visual analog scale

Time Frame: 24 weeks

Evaluate the reduction in Cervical Dentin Hypersensitivity with a 24 weeks follow up.

Study Sites (1)

Loading locations...

Similar Trials